Cases reported "Carcinoma, Hepatocellular"

Filter by keywords:



Filtering documents. Please wait...

1/25. Spontaneous rupture of hepatocellular carcinoma during pregnancy.

    BACKGROUND: Hepatocellular carcinoma associated with pregnancy is unusual. CASE: A 33-year-old woman presented at 25 weeks' gestation with sudden, severe epigastric pain for 6 hours. Abdominal ultrasonography and magnetic resonance imaging showed multiple liver tumors with a small amount of ascites. Exploratory laparotomy revealed an unresectable ruptured liver tumor that was treated by packing. Although a biopsy was nondiagnostic, ultrasound-guided needle biopsy 6 days after cesarean delivery at 41 weeks' gestation showed hepatocellular carcinoma, which was treated with transarterial embolization. At 3.5 years posttherapy, both mother and infant are well. CONCLUSION: Ruptured hepatocellular carcinoma during pregnancy is rare but should be included in the differential diagnosis of sudden, severe epigastric pain.
- - - - - - - - - -
ranking = 1
keywords = pregnancy
(Clic here for more details about this article)

2/25. Fibrolamellar hepatic carcinoma with a presentation similar to that of septic pregnancy. A case report.

    BACKGROUND: Of hepatocellular carcinomas, produce quantifiable levels of beta-hCG. CASE: A 44-year-old woman presented with fever, abdominal pain, vaginal bleeding and increased serum levels of beta-hCG. CONCLUSION: Nongestational elevations of serum beta-hCG warrant consideration of a malignant neoplasm.
- - - - - - - - - -
ranking = 0.66666666666667
keywords = pregnancy
(Clic here for more details about this article)

3/25. Aggressive hepatocellular carcinoma complicating pregnancy after autologous bone marrow transplantation for non-Hodgkin's lymphoma.

    In the Asia-Pacific region, autologous and allogeneic bone marrow transplantation (BMT) in patients infected with the hepatitis b virus (HBV) may be complicated by fatal hepatic failure due to viral reactivation. survivors may suffer from accelerated hepatitis and cirrhosis. We report the first case of hepatocellular carcinoma (HCC) after autologous BMT for mediastinal B cell lymphoma. The tumor developed rampantly during a planned pregnancy 5 years after BMT. Less than 40 cases of HCC complicating pregnancy have been reported, and outcome is invariably poor. immunosuppression and HBV reactivation after autologous BMT, as well as immune tolerance and hormonal changes associated with pregnancy may contribute to the rapid tumor growth. Biochemical and radiological surveillance for HCC should be strengthened in HBV carriers after BMT, especially in patients with the histology of chronic liver disease, or biochemical/ virological evidence of increased HBV activity.
- - - - - - - - - -
ranking = 1.1666666666667
keywords = pregnancy
(Clic here for more details about this article)

4/25. Hepatoma in pregnancy.

    We present the third case of hepatoma in pregnancy to be reported in an African. Despite the high incidence of hepatoma in the male population, hepatoma complicating pregnancy is very rare in this environment. death usually occurs within one year of onset of symptoms. The clinical features during pregnancy do not differ appreciably from its presentation in the non-pregnant state. However, after pregnancy, as demonstrated in our case, the disease appears to pursue a more rapid course. These observations lend more weight to suggestions of a hormonal dependence of hepatoma.
- - - - - - - - - -
ranking = 1.3333333333333
keywords = pregnancy
(Clic here for more details about this article)

5/25. Hepatobiliary complications of oral contraceptives.

    Complications secondary to the use of oral contraceptive agents are rare. Hepatobiliary complications, while often dramatic in presentation, occur infrequently. In a patient without predisposing conditions to complications, the benefits achieved with estrogen/progesterone products outweigh the risks. Those conditions that would absolutely and relatively contraindicate the use of oral contraceptives are listed in Table 4. patients with a past history of liver disease in whom liver function tests have returned to normal may tolerate the introduction of oral contraceptives. They need to be monitored closely for adverse reactions. patients who have experienced cholestatic jaundice of pregnancy should avoid all contraceptives because of a high risk of disease recurrence. women whose first-degree relatives have experienced cholestasis of pregnancy or oral contraceptive-induced cholestasis may be at increased risk and should be closely monitored while taking birth-control pills. women with current or previous benign or malignant hepatic tumors should not take oral contraceptives. Active hepatitis is an absolute contraindication to using birth control pills, although patients with a past history of hepatitis and no evidence of active disease can have a trial of these drugs with close follow-up. A final group of women who should avoid oral contraceptives is those with familial defects of biliary excretion, including the Dubin-Johnson syndrome, Rotor's syndrome, and benign intrahepatic recurrent cholestasis. Dubin-Johnson syndrome is often asymptomatic and may manifest only during pregnancy or during the use of oral contraceptives. The reduction in hepatic excretory function induced by the sex steroids can transform the mild hyperbilirubinemia into frank jaundice. Oral contraceptive agents are the most widely used reversible means of birth control currently available. Fortunately, the complications associated with these drugs are infrequent and may be decreasing due to lower-dose products. Complications still occur, however, and need to be recognized by the general internist as medication-induced problems so the offending drugs can be discontinued and appropriate treatment and follow-up initiated. In addition, patients at risk for the development of complications need to be recognized and advised prior to the introduction of oral contraceptives.
- - - - - - - - - -
ranking = 0.5
keywords = pregnancy
(Clic here for more details about this article)

6/25. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.

    BACKGROUND: Fibrolamellar carcinoma, a rare variant of hepatocellular carcinoma, and focal nodular hyperplasia, a benign lesion, are rare hepatic lesions that are known to occur in young women with noncirrhotic livers. Some have suggested that fibrolamellar carcinoma might be the malignant counterpart of focal nodular hyperplasia. The coexistence of the 2 lesions is very rare. CASES: Two cases of fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia followed long-term oral contraception, and 1 of the 2 occurred during pregnancy. CONCLUSION: Distinguishing fibrolamellar carcinoma from focal nodular hyperplasia has important implications for treatment and prognosis. One should be aware of such conditions, especially in patients with a long history of oral contraception.
- - - - - - - - - -
ranking = 0.16666666666667
keywords = pregnancy
(Clic here for more details about this article)

7/25. A case of the hepatocellular carcinoma during the pregnancy and metastasis to the left atrium.

    A 28-year-old female with a pregnant state of 29th gestational week was admitted because of nausea and vomiting. MRI showed a huge hepatocellular carcinoma. At the 36th gestational week, a normal delivery was done. Surgery of hepatocellular carcinoma was done at 20 days after delivery. After 22 months from the operation, pulmonary metastasis was found and resection of lung mass was done. About 3 years after resection, a low attenuating nodule was detected in the left atrial chamber of heart. We report a case of hepatocellular carcinoma with metastatic lesions to lung and heart in a pregnant woman.
- - - - - - - - - -
ranking = 0.66666666666667
keywords = pregnancy
(Clic here for more details about this article)

8/25. Evolution and management of a hepatocellular carcinoma during pregnancy.

    Coexistence of a hepatocellular carcinoma with pregnancy is extremely rare. The authors present the case of an African woman positive for hepatitis B surface antigen and referred to our hospital for suspected cervical incompetence in which a surgically unapproachable hepatocellular carcinoma was diagnosed. The patient refused termination of pregnancy or liver transplantation because of religious beliefs. In this case, the authors had the opportunity to follow the growth of the mass throughout the pregnancy and puerperium.
- - - - - - - - - -
ranking = 1.1666666666667
keywords = pregnancy
(Clic here for more details about this article)

9/25. Ruptured benign hepatoma associated with an oral contraceptive. A case report.

    A ruptured benign hepatoma is described in a woman at full-term pregnancy. The patient had used an oral contraceptive for eight years before she became pregnant. According to several recent reports it seems likely that there is a relationship between the use of oral contraceptive agents and the development of liver cell tumours. Twentythree such cases have been found in the literature. Fourteen of these were not diagnosed before rupture. The present tumour differed from previously described lesions by containing foci of haematopoietic cells. As there were no signs of blood or bone marrow disease, it is suggested that the extramedullary haematopoiesis is a constituent of the tumour tissue.
- - - - - - - - - -
ranking = 0.16666666666667
keywords = pregnancy
(Clic here for more details about this article)

10/25. A case of hepatocellular carcinoma in pregnancy detected by routine screening of maternal alpha-feto-protein.

    A rare case of hepatocellular carcinoma in a 31-year-old woman is reported. The diagnosis was made at 16 weeks of pregnancy when very high levels of alpha-feto-protein were found upon routine examination. The pregnancy was terminated and cytostatic therapy was given. The patient died one year later.
- - - - - - - - - -
ranking = 1
keywords = pregnancy
(Clic here for more details about this article)
| Next ->


Leave a message about 'Carcinoma, Hepatocellular'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.